Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026)
Nuwellis (NUWE) posted Income from Continuing Operations of 4541000.0 for Q1 2026, down 87.49% on a QoQ basis from 2422000.0 in Q4 2025, and down 50.66% year-over-year from 9204151.98 in Q1 2025.
Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Nuwellis' Income from Continuing Operations history runs 16 years deep, the most recent figure standing at 4541000.0 for Q1 2026.
- Quarterly Income from Continuing Operations fell 50.66% year-over-year to 4541000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19048000.0 (down 93.4% YoY) and the FY2025 annual result came in at 17521000.0, down 56.93% from the prior year.
- Income from Continuing Operations was 4541000.0 for Q1 2026 at Nuwellis, down from 2422000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 2358000.0 in Q3 2024 and bottomed at 12553000.0 in Q2 2025.
- A 5-year average of 4009235.29 and a median of 4286000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations plunged 353.2% — and 2024, when it surged 169.97%.
- Nuwellis' Income from Continuing Operations stood at 1374000.0 in 2022, then sank by 353.2% to 6227000.0 in 2023, then surged by 76.43% to 1468000.0 in 2024, then tumbled by 64.99% to 2422000.0 in 2025, then plunged by 87.49% to 4541000.0 in 2026.
- Business Quant data shows NUWE's Income from Continuing Operations at 4541000.0 in Q1 2026, 2422000.0 in Q4 2025, and 468000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.13 Bn | 175.84 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.86 Bn | 125.99 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.95 Bn | 99.73 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.42 Bn | 66.97 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.30 Bn | 44.63 Bn | 1.29 Bn | 380.70 Mn |
| 6 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 411.00 Mn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 199.50 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Nuwellis | 116,200.56 | -1.97 Mn | 1.68 Mn | -4.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.54 Mn |
| Dec 31, 2025 | -2.42 Mn |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | -12.55 Mn |
| Mar 31, 2025 | -3.01 Mn |
| Dec 31, 2024 | -1.47 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | -7.73 Mn |
| Mar 31, 2024 | -4.33 Mn |
| Dec 31, 2023 | -6.23 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | -4.85 Mn |
| Mar 31, 2023 | -6.49 Mn |
| Dec 31, 2022 | -1.37 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | -4.47 Mn |
| Dec 31, 2021 | 15.82 Mn |
| Sep 30, 2021 | -5.27 Mn |
| Jun 30, 2021 | -4.73 Mn |